Cargando…

Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients

OBJECTIVE: Cytoreductive surgery followed by adjuvant chemotherapy is a standard frontline treatment for epithelial ovarian cancer (EOC). We aimed to develop an ovarian cancer risk score (OVRS) based on the expression of 10 ovarian-cancer-related genes to predict the chemoresistance, and outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Hsiao-Yun, Tai, Yi-Jou, Chen, Yu-Li, Chiang, Ying-Cheng, Hsu, Heng-Cheng, Cheng, Wen-Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930441/ https://www.ncbi.nlm.nih.gov/pubmed/33327048 http://dx.doi.org/10.3802/jgo.2021.32.e18

Ejemplares similares

Outcome and prognostic factors of unexpected ovarian carcinomas
por: Cheng, Ching‐Yu, et al.
Publicado: (2022)

A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma
por: Hsieh, Shu-Feng, et al.
Publicado: (2019)

Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma
por: Chiang, Ying-Cheng, et al.
Publicado: (2015)

Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study
por: Huang, Hsin-Ying, et al.
Publicado: (2021)

Factors predicting parametrial invasion in patients with early-stage cervical carcinomas
por: Hsu, Heng-Cheng, et al.
Publicado: (2018)

Factors Influencing the Discordancy Between Intraoperative Frozen Sections and Final Paraffin Pathologies in Ovarian Tumors
por: Shen, Hung, et al.
Publicado: (2021)

Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan
por: Chiang, Ying-Cheng, et al.
Publicado: (2013)

Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Preoperative magnetic resonance imaging predicts clinicopathological parameters and stages of endometrial carcinomas
por: Wu, Chia‐Ying, et al.
Publicado: (2021)

FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014)

Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells
por: Qian, Xue-qian, et al.
Publicado: (2020)

Prediction of chemo-response in serous ovarian cancer
por: Gonzalez Bosquet, Jesus, et al.
Publicado: (2016)

Impact of Adjuvant Modalities on Survival in Patients with Advanced Stage Endometrial Carcinoma: A Retrospective Analysis from a Tertiary Medical Center
por: Tai, Yi-Jou, et al.
Publicado: (2019)

Use of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian Cancer
por: Richard, Scott, et al.
Publicado: (2015)

Outcome and Subsequent Pregnancy after Fertility-Sparing Surgery of Early-Stage Cervical Cancers
por: Lee, Chia-Yi, et al.
Publicado: (2020)

Risk Factors of Hypersensitivity to Carboplatin in Patients with Gynecologic Malignancies
por: Tai, Yu-Hsiao, et al.
Publicado: (2017)

Gene methylation of human ovarian carcinoma stromal progenitor cells promotes tumorigenesis
por: Ho, Chih-Ming, et al.
Publicado: (2015)

Recent perspectives of epithelial ovarian carcinoma
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)

Recent perspectives of epithelial ovarian carcinoma
por: Zhang, Xiao-Ying, et al.
Publicado: (2020)

Surgery in platinum-resistant recurrent epithelial ovarian carcinoma
por: Zhao, Ling-Qin, et al.
Publicado: (2022)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers
por: Mesquita, Katia A., et al.
Publicado: (2021)

Poorer prognosis of ovarian squamous cell carcinoma than serous carcinoma: a propensity score matching analysis based on the SEER database
por: Zhang, Cheng, et al.
Publicado: (2020)

Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model
por: Lu, Tzu-Pin, et al.
Publicado: (2019)

The Roles of Exosomes in Ovarian Cancer Chemo-resistance
por: Liu, Yang, et al.
Publicado: (2023)

Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
por: Hu, Yi, et al.
Publicado: (2023)

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015)

Increased expression of MMP17 predicts poor clinical outcomes in epithelial ovarian cancer patients
por: Xiao, Chao, et al.
Publicado: (2022)

Sema3E/Plexin-D1 Mediated Epithelial-to-Mesenchymal Transition in Ovarian Endometrioid Cancer
por: Tseng, Chun-Hsien, et al.
Publicado: (2011)

Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma
por: Chen, Chien-Wen, et al.
Publicado: (2013)

Epithelial Ovarian Carcinoma Types and the Coexistence of Ovarian Tumor Conditions
por: van Niekerk, Catharina. C., et al.
Publicado: (2011)

Ultrasound-based radiomics for predicting different pathological subtypes of epithelial ovarian cancer before surgery
por: Tang, Zhi-Ping, et al.
Publicado: (2022)

The Inhibitory Effect of Ellagic Acid on Cell Growth of Ovarian Carcinoma Cells
por: Chung, Yuan-Chiang, et al.
Publicado: (2013)

The role of EMMPRIN expression in ovarian epithelial carcinomas
por: Zhao, Yang, et al.
Publicado: (2013)

Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
por: Chen, Chien-An, et al.
Publicado: (2018)

Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies
por: Lee, Shu-Ping, et al.
Publicado: (2019)

Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments
por: Ali, Sajid, et al.
Publicado: (2021)

Epithelial–Mesenchymal Transition in Ovarian Carcinoma
por: Davidson, Ben, et al.
Publicado: (2012)

ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells
por: Yan, Hongchao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_46kfgeli88qpklij6afepsp41g